Hidradenitis suppurativa: A retrospective study of 846 Dutch patients to identify factors associated with disease severity - 14/08/14
Abstract |
Background |
Few comprehensive studies exist on the epidemiology of hidradenitis suppurativa, a very distressing skin disease.
Objective |
We sought to identify disease-related factors associated with severity, sex, and family history.
Methods |
Ordinal logistic regression was used in 846 consecutive Dutch patients with hidradenitis suppurativa to calculate odds ratios (ORs) for severity according to Hurley. Sex and family history were compared using Student t test and χ2 test.
Results |
In total, 45.5% of the patients had Hurley I, 41.5% had Hurley II, and 13.0% had Hurley III. Severity was associated with male sex (OR 2.11; P < .001), disease duration (OR 1.03; P < .001), body mass index (OR 1.03; P = .01), smoking pack-years (OR 1.02; P = .001), and axillary (OR 2.24; P < .001), perianal (OR 1.92; P < .001), and mammary lesions (OR 1.48; P = .03). Women had earlier onset, more inguinal and mammary lesions, and more frequent family history for hidradenitis suppurativa. Men more commonly had gluteal, perianal, and atypical lesions, and a history of severe acne. Patients with a family history had earlier onset, longer disease duration, a history of severe acne, more extensive disease, and were more often smokers.
Limitations |
Some parameters were patient-reported.
Conclusion |
The severity risk factors identified in this study could help physicians to select patients who need close monitoring and who would benefit from early, aggressive therapy.
Le texte complet de cet article est disponible en PDF.Key words : acne inversa, body mass index, cigarette smoking, disease severity, epidemiology, family history, Hurley stage, obesity, risk factors, sex, smoking pack-years
Abbreviations used : BMI, DM, HS, OR
Plan
| Funding sources: None. |
|
| Disclosure: Dr Prens received grants from AbbVie (Grant number: PSA 45232, February 6, 2011), and is on the advisory board of AbbVie. Dr Schrader, Deckers, van der Zee, and Boer have no conflicts of interest to declare. |
Vol 71 - N° 3
P. 460-467 - septembre 2014 Retour au numéro
Article précédent
- Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris
- Eubee Baughn Koo, Tyler Daniel Petersen, Alexandra Boer Kimball
- Omalizumab therapy for bullous pemphigoid
- Kenneth K. Yu, Ashley B. Crew, Kelly A.N. Messingham, Janet A. Fairley, David T. Woodley
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?